GLOBULIN SERUM, ANTI

GLOBULIN SERUM, ANTI-HUMAN, USP, in a 10 mL vial, is procured for use in detecting human IgG bound to red blood cells and must comply with strict technical and quality standards as defined in the DLA Master List of Technical and Quality Requirements. The product must have a non-extendable shelf life of 12 months, with at least two months remaining from the date of manufacture to the date of delivery to the government. All containers must be clearly marked with the lot number and date of manufacture prefixed by “MFD” and stored under refrigeration at 2 to 8 degrees Celsius. It is regulated by the FDA, and buyers must refer the bidder and manufacturer details to the product specialist via EBS for confirmation. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and each unit must be sealed in a protective container suitable for safe transport by common carriers. The item is to be delivered FOB destination within 84 days, with no tolerance for quantity variance, and inspected and accepted upon arrival. The manufacturer is ORTHO DIAGNOSTIC SYSTEMS INC, part number 716360, under NSN 6550-01-242-2234. All packaging must meet MIL-STD-2073-1E specifications, and the procurement is issued under solicitation SPE2DS-26-T-053K by the Department of Defense’s Medical Supply Chain, with delivery directed to APO, ZIP 96260-5479.